$40.41
Currently 20 wall-street analysts regularly analyze the financials of Crinetics Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 20 analysts offering 12-month price forecasts for Crinetics Pharmaceuticals Inc (CRNX) have a share price target of $80.27. This median of share price forecast represents a 98.63% upside from the latest price of $40.41 as on 24.10.25.
As per the chart shown above, analysts believe that the Crinetics Pharmaceuticals Inc (CRNX) share price will touch around $80.27 in next 12-months.
Below is a chart showing the percentage difference between Crinetics Pharmaceuticals Inc's share price and its median forecast price. As on 24.10.25, the difference is -48.16%
Based on 20 analysts tracking and researching Crinetics Pharmaceuticals Inc (CRNX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 12 | 12 | 12 |
| Outperform | 5 | 6 | 6 |
| Hold | 2 | 2 | 2 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |